Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Iron chelation in antimalarial therapy].

B Pradines1, J Millet, M Henry

  • 1L'Unité de Parasitologie, Institut de Médecine Tropicale du Service de Santé des Armées, Marseille, France. bruno.pradines@free.fr

Medecine Tropicale : Revue Du Corps De Sante Colonial
|August 13, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

State of the Art of Artificial Intelligence in Clinical Electrophysiology in 2025: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), and the ESC Working Group on E-Cardiology.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2025
Same author

Assessment of the Interelectrode Distance Effect over the Omnipole with High Multielectrode Arrays.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2023
Same author

Design, synthesis, and characterization of novel aminoalcohol quinolines with strong in vitro antimalarial activity.

European journal of medicinal chemistry·2021
Same author

What could explain the late emergence of COVID-19 in Africa?

New microbes and new infections·2020
Same author

Management and prevention of imported malaria. 2018 update of the 2007 French clinical guidelines.

Medecine et maladies infectieuses·2020
Same author

Changes in malaria epidemiology in France and worldwide, 2000-2015.

Medecine et maladies infectieuses·2019
Same journal

[Physiopathology of chronic arthritis following chikungunya infection in man].

Medecine tropicale : revue du Corps de sante colonial·2012
Same journal

[Judicial or administrative settlement of medical malpractice claims. Update on medical liability].

Medecine tropicale : revue du Corps de sante colonial·2012
Same journal

[Chikungunya epidemic in 2005-2006: questions from occupational health professionals].

Medecine tropicale : revue du Corps de sante colonial·2012
Same journal

[Administrative issues linked to health insurance coverage of chronic post-chikungunya rheumatism].

Medecine tropicale : revue du Corps de sante colonial·2012
Same journal

[Coverage of the chikungunya epidemic on Reunion Island in 2006 by the French healthcare system].

Medecine tropicale : revue du Corps de sante colonial·2012
Same journal

[Five-year outcome of mother-to-child transmission of chikungunya virus].

Medecine tropicale : revue du Corps de sante colonial·2012
See all related articles

Drug resistance necessitates novel antimalarial compounds. Iron(III)-chelating agents show promise, acting via iron deprivation or free radical damage against Plasmodium falciparum malaria.

Area of Science:

  • Medicinal Chemistry
  • Parasitology
  • Pharmacology

Context:

  • Antimalarial drug resistance is a significant global health challenge.
  • Iron(III)-chelating compounds, initially developed for other conditions, exhibit antimalarial properties.
  • Plasmodium falciparum malaria poses a severe threat, particularly in its complicated forms.

Purpose:

  • To explore the antimalarial potential of iron(III)-chelating compounds.
  • To investigate the mechanisms of action, including iron deprivation and free radical generation.
  • To evaluate the efficacy of these compounds in preclinical and clinical settings.

Summary:

  • Iron(III)-chelating agents demonstrate in vitro activity against malaria parasites.
  • These compounds function by limiting iron availability to the parasite or inducing oxidative stress.

Related Experiment Videos

  • Efficacy has been observed in animal models and human trials, notably with desferrioxamine.

    • Impact:

    • Iron-chelating agents represent a potential new class of antimalarial therapeutics.
    • They may serve as valuable adjunctive treatments for severe Plasmodium falciparum malaria.
    • Further research could lead to novel strategies to combat drug-resistant malaria strains.